Request TOC and Sample - Non-insulin Diabetes Therapeutic Market by Oral Antidiabetics (Sulfonylureas, Meglitinides, Thiazolidinediones, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-Glucosidase Inhibitors, Non-DPP-4 Inhibitors, Bile Acid Sequestrant, Incretin-Based Therapies), by Insulin Therapy (Rapid Acting Insulins, Short Acting Insulins, Intermediate Acting Insulins, Long Acting Insulins, Mixed Insulins), by Traditional glucocorticoid (Glucagon-like peptide-1 receptor agonists (GLP-1RAs)) and by Biosimilar (Biosimilar Insulin): Opportunity Analysis and Industry Forecast, 2023-2032

Non-insulin Diabetes Therapeutic Market, by Oral Antidiabetics (Sulfonylureas, Meglitinides, Thiazolidinediones, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-Glucosidase Inhibitors, Non-DPP-4 Inhibitors, Bile Acid Sequestrant, Incretin-Based Therapies), by Insulin Therapy (Rapid Acting Insulins, Short Acting Insulins, Intermediate Acting Insulins, Long Acting Insulins, Mixed Insulins), by Traditional glucocorticoid (Glucagon-like peptide-1 receptor agonists (GLP-1RAs)) and, by Biosimilar (Biosimilar Insulin): Opportunity Analysis and Industry Forecast, 2023-2032